Bifeprunox is a original atypical antipsychotic,dopamine D2 receptor partial agonist and 5-HT1A receptor agonist.Compared with other atypical antipsychotics,bifeprunox can not only produce a significant improvement of the positive symptoms and negative symptoms,but also improve cognitive impairment.Bifeprunox induced fewer extrapyramideal and metabolic adverse reactions.

Bifeprunox is an innovative atypical antipsychotic that significantly improves symptoms and cognitive impairment, with fewer adverse reactions compared to other drugs.

Paper

Research advance of innovative drug bifeprunox

References

Citations